Gianluca De Rubeis: A Safer Approach to Antiplatelet Timing in Endovascular Aneurysm Treatment
Gianluca De Rubeis, Interventional Neuroradiologist at San Camillo Forlanini Hospital, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Neuroradiology, adding:
”’The timing of intraprocedural antiplatelet therapy did not affect outcomes in endovascular treatment of ruptured intracranial aneurysms’ — our systematic review is now live.
Here’s the key takeaway: antiplatelet therapy — given to reduce thromboembolic complications — doesn’t need to be administered at the very start of the procedure.
It can be safely delayed until after the first coil is deployed, with no difference in outcomes.
Why does this matter?
Once the first coil is in place, the aneurysm is protected.
Giving antiplatelet therapy at that point keeps the same efficacy against clot complications — while making the overall procedure safer.
A simple but important shift in how we think about timing in the most critical moments of endovascular treatment.
Proud of this work and the incredible team behind it.”
Title: The timing of intraprocedural antiplatelet therapy did not affect outcomes in endovascular treatment of ruptured intracranial aneurysms: A systematic review
Authors: Gianluca De Rubeis, Sebastiano Fabiano, Luca Bertaccini, Alberto Vito Terrana, Riccardo Ricciuti, Luca Saba, Enrico Pampana
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering